Surmodics to Present at Jefferies Healthcare Conference

Rhea-AI Summary

Surmodics, Inc. (Nasdaq: SRDX) will present at the Jefferies 2022 Healthcare Conference on June 9, 2022, at 3:30 p.m. ET. CEO Gary Maharaj and CFO Tim Arens will discuss the company's innovative medical device and diagnostic technologies. A live audio webcast of this event can be accessed here or through the Investor Relations section of their website. The presentation will be archived for 90 days post-event. Surmodics focuses on enhancing disease detection and treatment through advanced surface modification technologies.

Webcast is Live on Thursday, June 9, at 3:30 p.m. (ET)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced Gary Maharaj, president and chief executive officer, and Tim Arens, senior vice president of finance and chief financial officer, will make a presentation to the investment community at the Jefferies 2022 Healthcare Conference in New York City on Thursday, June 9, 2022, at 3:30 p.m. ET. A live audio webcast of the presentation will be available at the following link: https://wsw.com/webcast/jeff240/srdx/1871025. Additionally, access the live audio webcast by navigating to the upcoming events under the investor relations portion of the Company’s website at https://surmodics.gcs-web.com/events-and-presentations and clicking on the webcast icon. The webcast will be archived on the Company’s website for 90 days following the live presentation.

About Surmodics, Inc.

Surmodics is a leading provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing development and commercialization of highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the Company makes with the Securities and Exchange Commission (“SEC”).

View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005126/en/

Tim Arens

952-500-7000

ir@surmodics.com

Source: Surmodics, Inc.

FAQ

When is Surmodics' presentation at the Jefferies 2022 Healthcare Conference?

Surmodics, Inc. will present at the Jefferies 2022 Healthcare Conference on June 9, 2022, at 3:30 p.m. ET.

Who will represent Surmodics at the Jefferies Healthcare Conference?

CEO Gary Maharaj and CFO Tim Arens will represent Surmodics at the conference.

How can I listen to the Surmodics presentation live?

You can access the live audio webcast of Surmodics' presentation at this link: https://wsw.com/webcast/jeff240/srdx/1871025.

Will the Surmodics presentation be available after the live event?

Yes, the presentation will be archived on Surmodics' website for 90 days following the live event.

What is Surmodics' focus in the medical industry?

Surmodics focuses on developing surface modification technologies for medical devices and diagnostic tests to improve disease detection and treatment.